Minimal residual disease in Philadelphia-positive acute lymphoblastic leukemia: Maximizing the clinical yield of testing. Saliba AN, Foa R. Am J Hematol 2023 Jun 14. doi: 10.1002/ajh.26993.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Saliba AN, Foa R. Minimal residual disease in Philadelphia-positive acute lymphoblastic leukemia: Maximizing the clinical yield of testing. Am J Hematol 2023 Jun 14. doi: 10.1002/ajh.26993.
PMID: 37314420